Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Conscious Capitalism Is Planting Its Roots In The Investment Market

2018-07-13 seekingalpha
Companies that do not actively participate in sustainable business practices are considered out of touch - and, in extreme cases, unethical.
WPM ABX AKG ROGFF GG TU AKG ABX

0
Asanko Gold Announces Q2 2018 Production Results

2018-07-12 globenewswire
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE American:AKG) announces production results for the second quarter (“Q2”) of 2018 from the Asanko Gold Mine (“AGM”), located in Ghana, West Africa.
AKG AKG

13
AKG / Asanko Gold Inc. null (Current Report of Foreign Issuer)

2018-06-22 sec.gov
F6K20180622 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of Ju
AKG

9
Asanko Gold Receives Ghana Government Approval for US$185 Million Gold Fields Joint Venture Transaction

2018-06-22 globenewswire
VANCOUVER, British Columbia, June 22, 2018 (GLOBE NEWSWIRE) -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE MKT:AKG) is pleased to announce that it has received approval from the Ghanaian Minister of Lands and Natural Resources, whose approval was the principal condition to the closing of Asanko’s previously announced joint venture transaction (the “Transaction”) with Gold Fields Limited (JSE, NYSE: GFI) for a 50% interest in Asanko’s 90% interest in the Asanko Gold Mine in Ghana, West Africa.
GFI.WI AKG GFI GFIOF AKG

15
AKG / Asanko Gold Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-06-08 sec.gov
Asanko Gold Inc. - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2018 Commission File No. 001-33580
AKG

12
Asanko Gold Results of Annual General Meeting

2018-06-08 globenewswire
VANCOUVER, British Columbia, June 08, 2018 (GLOBE NEWSWIRE) -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE MKT:AKG) announced that all the resolutions put to shareholders at the Company’s annual general meeting (the “Meeting”) held on June 8, 2018 were duly passed. The results for each of the matters voted upon at the Meeting are set out below:
AKG AKG

18
Gold Fields Will Play Smart In 2019 And Beyond

2018-06-08 seekingalpha
However Golf Fields' financial performance and strong portfolio of mining assets indicate a promising outlook beyond the one-year horizon.
AULGF GFI.WI AKG AU GFI AGG GFIOF AKG

5
AKG / Asanko Gold Inc. null

2018-06-05 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0Y(# @;V)J#3P\+TQI;[email protected](O5'EP92]84F5F+U=;,2 R(#%=/CYS=')E86T-"FC>8F)[email protected] M8F#R!!(,4X [email protected](")#[email protected]<1'308F1H8#(%D&1G3B/^/D/P [email protected]"TE0;D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HV,2 P(&]B:@T\/"]#(#8Y+T9I;'1E
AKG

9
Gold Fields to set aside acquisitions, sees industry costs rising-CEO

2018-05-30 reuters
LIMA, May 30 (Reuters) - South Africa’s Gold Fields is setting aside pursuit of new acquisitions for a year as it focuses on its existing operations and nearby prospects instead, the bullion producer’s chief executive told Reuters late on Tuesday.
GFI.WI AKG GFI GFIOF AKG

10
Asanko Gold' (AKG) CEO Peter Breese on Q1 2018 Results - Earnings Call Transcript

2018-05-11 seekingalpha
Good morning, ladies and gentlemen, and welcome to the Asanko Gold Q1 2018 Operating and Financial Results Conference Call and Webcast, which is being recorded. A copy of today's press release, the management discussion and analysis, and the presentation is available on the company's website at www.asanko.com.
GFI.WI AKG GFI GFIOF AKG

10
Asanko Gold Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-10 seekingalpha
The following slide deck was published by Asanko Gold Inc. in conjunction with their 2018 Q1 earnings call.
AKG AKG

7
AKG / Asanko Gold Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-05-10 sec.gov
Asanko Gold Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2018 Commission File No. 00
AKG

8
AKG / Asanko Gold Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-05-10 sec.gov
Asanko Gold Inc. - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2018 Commission File No. 001-33580 <
AKG

10
AKG / Asanko Gold Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-05-07 sec.gov
Asanko Gold Inc.: Form 6-K- Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2018 Commissio
AKG

7
Asanko Gold Publishes 2017 Corporate Social Responsibility Report 

2018-05-07 globenewswire
VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE American:AKG) today publishes its 2017 Corporate Social Responsibility (“CSR”) Report, which provides a detailed review of Asanko’s CSR strategy and performance during the year, including its contribution to both the local communities in which it operates and its host country, Ghana.
AKG AKG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 04341Y105